CONSOLIDATED BALANCE SHEETS - USD ($)	Dec. 31, 2021	Dec. 31, 2020
CURRENT ASSETS
Cash	$ 96,198	$ 68,047
Advances to Supplier		154,893
Inventory	258,781	0
TOTAL CURRENT ASSETS	354,979	222,940
FIXED ASSETS (net of Depreciation)	31,783	36,803
TOTAL ASSETS	386,762	259,743
CURRENT LIABILITIES
Accounts payable and accrued expenses	186,528	251,187
Notes payable	258,292	175,047
Convertible Notes Payable	876,363	170,758
PPP Loan		231,500
Derivative liabilities
TOTAL CURRENT LIABILITIES	1,321,183	828,492
TOTAL LIABILITIES	1,321,183	828,492
STOCKHOLDERS’ DEFICIENCY
Preferred Stock – Par Value of $0.001; 25,000,000 shares authorized; 1,000,000 and 0 shares issued and outstanding as of September 30, 2020 and December 31, 2019	1,000	1,000
Common Stock - Par Value of $0.001; 50,000,000 shares authorized; 51,920,387 and 50,782,116 shares issued and outstanding as of December 31, 2021 and 2020, respectively	51,921	50,782
Additional paid-in capital	1,333,567	1,333,356
Accumulated deficit	(2,320,909)	(1,953,887)
TOTAL STOCKHOLDERS’ DEFICIENCY	(934,421)	(568,749)
TOTAL LIABILITIES & STOCKHOLDERS’ DEFICIENCY	$ 386,762	$ 259,743

Sum of the carrying values as of the balance sheet date of obligations incurred through that date and due within one year (or the operating cycle, if longer), including liabilities incurred (and for which invoices have typically been received) and payable to vendors for goods and services received, taxes, interest, rent and utilities, accrued salaries and bonuses, payroll taxes and fringe benefits.

Name:	us-gaap_AccountsPayableAndAccruedLiabilitiesCurrent
Namespace Prefix:	us-gaap_
Data Type:	xbrli:monetaryItemType
Balance Type:	credit
Period Type:	instant

- Definition

Amount of excess of issue price over par or stated value of stock and from other transaction involving stock or stockholder. Includes, but is not limited to, additional paid-in capital (APIC) for common and preferred stock.